European GP practices are under significant administrative pressure. Waiting lists are growing, consultation times are shrinking, and clinicians spend a disproportionate share of their working day on documentation rather than direct patient care. Artificial intelligence documentation tools—including ambient scribes, real-time transcription assistants, and automated clinical note generators—are widely promoted by vendors and health technology commentators as a direct solution to this problem. Yet uptake across European primary care remains strikingly uneven. The technology exists. The problem it claims to solve is real. So why aren't more GPs using it?

The answer is not simple resistance. When clinicians are asked directly—in surveys, focus groups, and qualitative interviews—a layered set of concerns emerges that are rational, specific, and largely unaddressed by the current generation of artificial intelligence documentation products. Understanding these concerns is essential for anyone involved in procuring, deploying, or building artificial intelligence tools for European healthcare settings.

The implementation paradox: "I don't have time to learn a new system right now"

The most immediate barrier GPs describe is also the most counterintuitive. The very problem that artificial intelligence documentation tools are designed to solve—the crushing weight of admin burden—is frequently cited as the reason clinicians cannot find the time to evaluate or adopt them.

A landmark 2025 survey of 1,005 UK GPs published in Digital Health found that 75 per cent were still not using generative artificial intelligence tools in clinical practice. Of those who did use them, only 35 per cent applied them to post-appointment documentation—the core use case most artificial intelligence documentation vendors target. Critically, 85 per cent of GPs reported their employer had not encouraged them to use generative artificial intelligence tools, and 95 per cent had received no professional training in how to use them.

This is not a story about clinicians who have tried artificial intelligence tools and rejected them. It is largely a story about clinicians who have never had the institutional support to try them at all. Without protected time for evaluation, structured onboarding, or a designated person to lead implementation, the cognitive load of adopting a new system falls entirely on individual clinicians who are already working at full capacity.

A qualitative study of Lithuanian family physicians found that even minor inefficiencies—including a 15 to 20 second processing delay in artificial intelligence-generated output—were perceived as serious problems in high-pressure clinical environments. When every second of a consultation is accounted for, any tool that introduces friction, however small, is likely to be abandoned.

How do I know it's actually accurate?

Trust in the accuracy of artificial intelligence-generated clinical notes is a persistent and legitimate concern. GPs are not simply being cautious for its own sake. They are responding to a genuine accountability question: if an artificial intelligence assistant misrepresents what was said in a consultation, or generates an inaccurate clinical code, the clinician—not the vendor—bears the legal and professional responsibility.

The companion opinion paper to the 2025 UK GP survey found that GPs' open-ended comments clustered around themes of unfamiliarity, ambivalence, and anxiety about artificial intelligence's role in clinical tasks. While 69 per cent of GPs believed artificial intelligence would improve documentation—up from 59 per cent in 2024, suggesting attitudes are gradually shifting—adoption continues to lag well behind stated optimism.

The Royal College of General Practitioners' December 2025 research report captured this tension directly. GPs in focus groups cautioned against overestimating the time-saving potential of artificial intelligence tools, noting that if you "spend the time to check things in a lot of detail, the time saving benefits might be diminished." This is a clinically responsible position. If a GP must read every artificial intelligence-generated note word for word before signing it off, the efficiency gain may be marginal or non-existent.

A 2025 Italian study on the optimism-knowledge gap among clinicians found that healthcare professionals are broadly enthusiastic about artificial intelligence but lack the specific knowledge needed to evaluate its reliability in practice—a gap that makes meaningful, informed adoption difficult.

Concerns about accuracy extend specifically to structured data and clinical codes. Errors in free-text notes are one thing. Errors in coded diagnoses or medication records carry downstream consequences for patient safety, referral pathways, and population-level data quality.

What happens to my patients' data?

Data security and privacy concerns are particularly acute in European primary care, where General Data Protection Regulation compliance is a legal baseline rather than an optional consideration. When GPs ask "Is this even legal in my country?", they are not being obstructionist. They are asking a question that many artificial intelligence documentation vendors have not answered clearly enough.

The companion UK GP opinion survey found that clinicians specifically voiced concerns about "third parties having access to patient data"—a concern that is structurally reasonable given that most artificial intelligence documentation tools process audio or text on cloud infrastructure that may sit outside the EU.

The RCGP report found that GPs raised questions about where patient data is stored, whether it is used for commercial purposes, and whether sharing patient data genuinely benefits the individuals whose data is being used. These are not hypothetical concerns. They reflect real ambiguity in how many artificial intelligence tools handle data residency and secondary use.

The European General Practice Research Network keynote paper on artificial intelligence in European primary care raised additional concerns specific to the European research context: data ownership, data poisoning, and the risk of data leakage—particularly relevant when patient conversations are processed by third-party artificial intelligence infrastructure.

A major EU-commissioned study on artificial intelligence deployment in European healthcare identified legal and regulatory complexity as one of four primary barrier categories, noting that both providers and patients worry about artificial intelligence reliability and data protection. The report found that most EU Member States lack clear reimbursement pathways for artificial intelligence tools, and that adoption is currently concentrated in larger academic hospitals rather than primary care settings, where data governance infrastructure is often less developed.

Our medical record system is ancient—will it even work?

Integration with existing medical record systems is a practical constraint that vendors frequently underestimate. In reality, the IT infrastructure of European primary care is heterogeneous, often ageing, and rarely designed with third-party artificial intelligence integration in mind.

The Spanish proof-of-concept study from Catalonia, which tested an artificial intelligence clinical note generation tool called "Relisten" in primary care settings, surfaced exactly these friction points: medical record system workflow integration, time measurement challenges, and the difficulty of benchmarking artificial intelligence-generated documentation against existing documentation standards in real clinical environments.

The EU healthcare artificial intelligence deployment report categorised technological and data issues as a distinct barrier category, separate from regulatory or organisational concerns. Legacy systems in European public healthcare—many of which were not designed to expose application programming interfaces or accept structured input from external tools—represent a genuine technical obstacle that cannot be resolved at the practice level.

For GPs working in public healthcare settings, the decision to integrate a new artificial intelligence tool is rarely theirs alone to make. It typically requires IT department involvement, procurement approval, and in some cases national or regional health authority sign-off. The gap between a clinician downloading an app and an artificial intelligence tool being formally integrated into a practice's medical record system workflow is substantial.

Nobody at the practice has signed off on this

Individual clinical interest in artificial intelligence documentation tools does not automatically translate into institutional adoption. Many GPs describe a situation in which they are personally curious about artificial intelligence assistants but face organisational or governance barriers that prevent them from moving forward.

The 2025 UK GP survey makes this structural problem explicit: 85 per cent of GPs said their employer had not encouraged them to use generative artificial intelligence tools, and 95 per cent had received no professional training. This is not a picture of a workforce that has been offered artificial intelligence tools and declined them. It is a picture of a workforce that has largely been left to navigate artificial intelligence adoption without institutional support.

The German physician attitudes study from RWTH Aachen University found that despite enthusiasm among individual physicians, clinical integration remained limited due to concerns about usability, ethical implications, and physician acceptance. The study called explicitly for standardised implementation strategies rather than leaving adoption to individual initiative.

Governance concerns also include questions about clinical accountability. If an artificial intelligence-generated note contains an error, who is responsible? If a tool has not been formally approved by a practice's clinical lead or by a national regulatory body, individual GPs may be reluctant to use it even if they believe it would help—precisely because the accountability framework is unclear.

I've seen too many tools come and go

Clinician scepticism rooted in past experience is a factor that does not always appear in surveys but surfaces consistently in qualitative research. GPs have lived through multiple cycles of health technology promises—from medical record system implementations that took years to stabilise, to clinical decision support tools that were mandated and then quietly abandoned—and this history shapes how they evaluate new tools.

The European General Practice Research Network keynote paper noted directly that the pace of artificial intelligence integration is outstripping the available evidence supporting its efficacy and safety. For clinicians trained to evaluate interventions against evidence, this is a meaningful concern. A tool shown to reduce documentation time in a vendor-sponsored pilot study is not the same as a tool with a robust evidence base from independent real-world evaluation.

The Polish mixed-methods study found that artificial intelligence adoption remains limited due to reluctance to change, misperceptions, and knowledge gaps. It also noted that concerns about job displacement have largely eased, with artificial intelligence increasingly viewed as augmenting rather than replacing clinicians. This is progress, but it does not automatically translate into trust in specific tools.

The PubMed-indexed survey of primary care clinicians on clinical decision support for HIV pre-exposure prophylaxis found that even when clinicians rated a tool as appropriate and useful, uptake was hindered by workflow and usability barriers—underscoring that perceived value and actual adoption are not the same thing. Under-supported rollouts, poor change management, and tools that don't fit real workflows have left a residue of caution that new artificial intelligence documentation products must contend with.

I'm not sure it would actually help my workflow

Even GPs who are open to artificial intelligence documentation tools often express doubt about whether existing products are designed for how they actually work. European primary care encompasses a wide range of consultation formats, languages, and documentation requirements that do not always match the use cases artificial intelligence tools were built for.

The RCGP report found that GPs identified administration as a key area where artificial intelligence could help. Their focus groups also revealed scepticism about whether artificial intelligence tools could deliver on that promise in practice, particularly around the time required to verify artificial intelligence-generated content.

The European General Practice Research Network keynote paper highlighted that the practical value of artificial intelligence tools depends heavily on clinicians' prompt engineering skills—a capability gap that most GPs have not had the training to address. An artificial intelligence documentation tool that requires significant configuration or prompting to produce useful output is not well-suited to the time-pressured reality of a GP consultation.

Remote and virtual consultations add further complexity. Ambient voice technology designed for in-person consultations may not function reliably in telephone or video triage settings. Multilingual patient interactions, common in urban European practices, introduce additional challenges around transcription accuracy and note quality. The Lithuanian qualitative study found that physicians remained sceptical of artificial intelligence's reliability and efficiency, with trust, data privacy, and physician autonomy all identified as persistent concerns—concerns that are amplified when the tool is perceived as not quite fitting the clinical context.

The artificial intelligence readiness study of young European family doctors published in the Annals of Family Medicine assessed readiness across four dimensions—cognition, ability, vision, and ethics—and found meaningful variation across countries, suggesting that the adoption gap is not uniform and is shaped by structural as well as individual factors.

What does it cost, and who pays for it?

Budget uncertainty is a significant and underreported barrier, particularly in European public healthcare systems where purchasing decisions are subject to procurement rules and central funding constraints.

The EU healthcare artificial intelligence deployment report found that most EU Member States lack reimbursement pathways for artificial intelligence tools, and that organisational and financial obstacles constitute one of the four primary barrier categories to artificial intelligence adoption in European healthcare. Without a clear mechanism for funding artificial intelligence documentation tools—whether through national health budgets, practice-level spending, or reimbursement from insurers—individual practices are left to absorb costs that may be difficult to justify in resource-constrained environments.

Pricing models for artificial intelligence documentation tools vary considerably and are not always transparent. Subscription-based models, per-consultation fees, and enterprise licensing arrangements each create different financial dynamics for practices of different sizes. In mixed healthcare systems, where GPs may see both publicly funded and privately funded patients, the question of which consultations fall under which pricing tier adds further complexity.

The qualitative UK patient study on artificial intelligence in primary care for patients with multiple long-term conditions found that implementation challenges and acceptance factors are closely linked, and that financial and organisational barriers interact with clinical and social ones in ways that make adoption a system-level challenge rather than an individual decision.

What these objections actually tell us about adoption

The concerns European GPs raise about artificial intelligence documentation tools are not a catalogue of irrational resistance. They are a coherent set of questions about trust, fit, governance, and support—questions that the current generation of artificial intelligence documentation products, and the health systems responsible for deploying them, have not yet answered convincingly enough to drive widespread adoption.

The barriers cluster into four broad categories:

• Trust and accuracy: clinicians need confidence that artificial intelligence-generated notes are reliable enough to sign off without extensive review, and that errors in structured data and clinical coding will not create downstream patient safety risks.

• Data governance: GDPR compliance, data residency, and clarity about secondary data use are non-negotiable for European clinicians operating under legal obligations that vary by country.

• Integration and fit: tools that do not connect reliably to existing medical record systems, or that were not designed for the specific consultation formats and linguistic diversity of European primary care, will not be adopted regardless of their technical capability.

• Institutional readiness: individual clinician interest is not sufficient. Adoption requires employer encouragement, professional training, governance frameworks, and in many cases central funding or reimbursement pathways.

The 2025 UK GP survey finding that 95 per cent of GPs had received no professional training in generative artificial intelligence tools is perhaps the single most important data point for anyone seeking to understand why adoption remains low. It suggests that the primary gap is not in clinician attitudes—which are becoming more positive—but in the institutional infrastructure required to support responsible, informed adoption.

For health system leaders and procurement decision-makers, the implication is that building a business case for deploying artificial intelligence documentation tools is not primarily a technology problem. It is an implementation problem—one that requires investment in training, governance, integration support, and clear communication about data handling before clinicians can reasonably be expected to change how they work.

Frequently asked questions

Why aren't more European GPs using artificial intelligence documentation tools?

The evidence suggests the main barrier isn't resistance to the technology itself. A 2025 survey of 1,005 UK GPs found that 85 per cent had received no encouragement from their employer to use generative artificial intelligence tools, and 95 per cent had received no professional training. Most GPs haven't had the institutional support needed to try these tools at all.

What do GPs say about the accuracy of artificial intelligence-generated clinical notes?

Accuracy is a persistent concern, and a practical one. If a GP must read every artificial intelligence-generated note in detail before signing it off, the time saving may be marginal. Errors in structured data and clinical coding carry downstream risks for patient safety and referral pathways. The clinician—not the vendor—bears legal and professional responsibility for what goes into the record.

How do GDPR and data privacy affect artificial intelligence documentation tool adoption in Europe?

General Data Protection Regulation compliance is a legal baseline for European clinicians, not an optional consideration. GPs have raised specific concerns about third parties accessing patient data, where data is stored, whether it's used for commercial purposes, and whether patients genuinely benefit from sharing their data. Many artificial intelligence documentation tools process audio or text on cloud infrastructure that may sit outside the EU, which creates real ambiguity around data residency and secondary use.

Why does integration with existing medical record systems cause problems?

European primary care runs on heterogeneous, often ageing IT infrastructure that wasn't designed with third-party artificial intelligence integration in mind. Many legacy systems in public healthcare don't expose application programming interfaces or accept structured input from external tools. For GPs in public healthcare settings, integrating a new artificial intelligence tool typically requires IT department involvement, procurement approval, and sometimes national or regional health authority sign-off.

What organisational barriers prevent individual GPs from adopting artificial intelligence tools?

Personal interest in artificial intelligence documentation tools doesn't automatically translate into practice-level adoption. Without employer encouragement, professional training, and clear governance frameworks, individual clinicians are left to navigate adoption alone while already working at full capacity. A German study from RWTH Aachen University found that clinical integration remained limited despite individual enthusiasm, and called explicitly for standardised implementation strategies.

Does the time it takes to learn a new artificial intelligence tool put GPs off using one?

Yes, and it's a counterintuitive problem. The admin burden that artificial intelligence documentation tools are designed to reduce is itself cited as the reason clinicians can't find time to evaluate or adopt them. A qualitative study of Lithuanian family physicians found that even a 15 to 20 second processing delay in artificial intelligence-generated output was perceived as a serious problem in high-pressure clinical environments.

Are artificial intelligence documentation tools actually designed for how European GPs work?

Many GPs doubt it. European primary care involves a wide range of consultation formats, languages, and documentation requirements. Ambient voice technology built for in-person consultations may not function reliably in telephone or video triage settings. Multilingual patient interactions, common in urban European practices, introduce additional challenges around transcription accuracy. The European General Practice Research Network has also noted that the practical value of artificial intelligence tools depends heavily on clinicians' prompt engineering skills—a capability gap most GPs haven't had training to address.

Who pays for artificial intelligence documentation tools in European public healthcare?

Funding is a significant and underreported barrier. A major EU-commissioned study on artificial intelligence deployment in European healthcare found that most EU Member States lack clear reimbursement pathways for artificial intelligence tools, and that organisational and financial obstacles are among the four primary barrier categories to adoption. Without a mechanism for funding these tools through national health budgets, practice-level spending, or insurer reimbursement, individual practices are left to absorb costs that can be difficult to justify in resource-constrained settings.

What would actually drive wider adoption of artificial intelligence documentation tools in primary care?

The evidence points to an implementation gap rather than an attitude gap. Clinician attitudes are becoming more positive, with 69 per cent of UK GPs believing artificial intelligence would improve documentation in 2025, up from 59 per cent in 2024. What's missing is the institutional infrastructure to support responsible adoption: employer encouragement, professional training, clear data governance, reliable integration with existing medical record systems, and in many cases central funding or reimbursement pathways.